In the present study, we investigated the expression of CEACAM6 in patients with intrahepatic cholangiocarcinoma using real-time quantitative reverse transcription–polymerase chain reaction (RT-PCR) to analyse the association of clinicopathological factors and prognosis with CEACAM6 expression levels. The gene discussed is CEACAM6; the disease is intrahepatic cholangiocarcinoma.